Mission and Goals
The mission of the MASCC Oncodermatology Study Group is to develop research and management strategies for skin conditions due to cancer or anticancer drugs. Skin reactions are frequent in those affected by cancer. They can reduce quality of life and require modifications in lifesaving antineoplastic therapy. This interdisciplinary study group aims to raise awareness of dermatological conditions in cancer patients and take a leadership role in the emerging field of cancer-related skin toxicities management.
The objectives of the Oncodermatology Study Group include the following:
- To identify new targets for the treatment of skin reactions
- To establish guidelines for management
- To contribute to patients’ knowledge of reactions and their care
Key efforts are directed toward the identification of phenotypes and treatment regimens with a higher risk, as well as preventive measures and early intervention as standards of care. This study group also serves as a resource for multi-center clinical trials and translational studies.
Evidence-based clinical practice guidelines created by the Oncodermatology Study Group